Physician profile
Dawn Dickson Black
NPI 1710980909
$3,562.87
in general payments reported to CMS, 2019-2025
36 companies · $605 in 2025
The $605 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $510 · 2020: $287 · 2021: $573 · 2022: $699 · 2023: $542 · 2024: $348 · 2025: $605.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,493.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $578.51 | 2019-2023 | Liletta, Orilissa, Lo Loestrin Fe |
| Exeltis, USA INC. | $431.43 | 2020-2025 | Slynd, Nuvessa, Tyblume |
| Astellas Pharma US INC | $319.46 | 2019-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $270.26 | 2019-2024 | |
| Hologic Sales and Service, LLC | $178.69 | 2019-2025 | Novasure, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Medtronic, INC. | $175.98 | 2023-2025 | Venaseal, V-Loc 180 |
| Exact Sciences Corporation | $150.79 | 2023-2025 | Cologuard Collection Kit |
| Coopersurgical, INC. | $146.09 | 2019-2024 | Advincula Delineator Uterine Manipulator |
| Agile Therapeutics, INC. | $133.32 | 2021-2024 | Twirla |
| Bayer Healthcare Pharmaceuticals INC. | $121.20 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $118.63 | 2023 | |
| Myovant Sciences INC. | $101.78 | 2021-2022 | |
| Medicem INC. | $80.93 | 2020-2022 | |
| Organon LLC | $79.96 | 2021-2022 | |
| Millicent US INC | $78.78 | 2019-2020 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $61.50 | 2019-2022 | |
| Aspira Women'S Health INC | $59.38 | 2022-2024 | Ova1 |
| Lupin INC. | $55.57 | 2019-2020 | |
| Renovia INC | $45.51 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $43.33 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $41.80 | 2025 | Qelbree |
| Sage Therapeutics, LLC | $41.80 | 2025 | Zurzuvae |
| Allergan, INC. | $34.20 | 2019-2020 | |
| Avion Pharmaceuticals | $28.95 | 2020-2021 | |
| Smith+Nephew, INC. | $28.59 | 2024 | Pico 7 |
| Evofem Biosciences, INC. | $22.65 | 2024 | |
| Medline Industries LP | $22.36 | 2024 | |
| Mylan Pharmaceuticals INC. | $20.47 | 2020 | |
| Vertical Pharmaceuticals, LLC | $19.14 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.76 | 2019 | |
| Shield Therapeutics INC | $15.63 | 2025 | |
| Sumitomo Pharma America, INC. | $14.59 | 2023 | Myfembree |
| Amgen INC. | $13.98 | 2024 | Prolia, Evenity |
| Scynexis, INC. | $11.85 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Black listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.